Europe Molecular Diagnostics Services Market
시장 규모 (USD 10억)
연평균 성장률 :
% 
 예측 기간 |
2023 –2030 |
 시장 규모(기준 연도) |
USD 32,964.59 Thousand |
 시장 규모(예측 연도) |
USD 57,370.93 Thousand |
 연평균 성장률 |
% |
| 주요 시장 플레이어 |
>유럽 분자 진단 서비스 시장, 서비스 유형별(기기 수리 서비스, 교육 서비스, 규정 준수 서비스, 교정 서비스 , 유지 관리 서비스, 확장 가능한 자동화 서비스, 턴키 서비스, 기기 이전 서비스, 하드웨어 사용자 정의, 성능 보증 서비스, 설계 및 개발 서비스, 공급망 솔루션, 신제품 출시 서비스, 제조 서비스, 환경 및 규제 서비스, 의료 관리 시스템 인증 및 감사, 임상 연구 서비스, 컨설팅 서비스 및 기타 서비스), 기술(PCR, 실시간 PCR, 차세대 시퀀싱 및 기타 기술), 최종 사용자( 병원 , 진단 센터, 학술 및 연구 기관 및 기타) 산업 동향 및 2030년까지의 예측.
유럽 분자 진단 서비스 시장 분석 및 통찰력
테스트, 치료법 및 더 빠른 진단에 대한 수요 증가는 전반적인 시장 성장을 촉진하는 데 도움이 되고 있습니다. 분자 진단 부문의 자금 조달 증가도 시장 성장에 기여하고 있습니다. 주요 시장 참여자들은 다양한 새로운 진단 서비스에 매우 집중하고 있습니다. 또한 만성 및 감염성 질환의 유병률 증가도 시장 수요 증가에 기여하고 있습니다.
유럽 분자 진단 서비스 시장은 시장 참여자의 증가와 시장에서 다양한 고급 분자 진단 서비스의 가용성으로 인해 예측 연도에 성장하고 있습니다. 이와 함께 정부 및 민간 협업의 수가 시장에서 증가하여 시장 성장을 더욱 촉진하고 있습니다. 그러나 분자 진단 실험실 설치 및 기타 계측과 관련된 높은 비용은 예측 기간 동안 시장 성장을 방해할 수 있습니다.
주요 시장 참여자들의 전략적 이니셔티브, 정부와 민간의 협력 증가, 그리고 증가하는 R&D 활동은 시장 성장의 기회를 제공하고 있습니다. 그러나 정부의 엄격한 규제와 숙련된 전문가의 부족은 시장 성장의 주요 과제입니다.
유럽 분자진단 서비스 시장은 2022년 32,964.59만 달러에서 2030년 57,370.93만 달러로 성장할 것으로 예상되며, 2023년에서 2030년까지의 예측 기간 동안 연평균 성장률은 7.4%로 성장할 것으로 예상됩니다.
|
보고서 메트릭 |
세부 |
|
예측 기간 |
2023년부터 2030년까지 |
|
기준 연도 |
2022 |
|
역사적 해 |
2021 (2020-2016까지 사용자 정의 가능) |
|
양적 단위 |
수익 (USD 천) |
|
다루는 세그먼트 |
서비스 유형별(계측기 수리 서비스, 교육 서비스, 규정 준수 서비스, 교정 서비스, 유지 보수 서비스, 확장 가능한 자동화 서비스, 턴키 서비스, 계측기 이전 서비스, 하드웨어 사용자 정의, 성능 보증 서비스, 설계 및 개발 서비스, 공급망 솔루션, 신제품 출시 서비스, 제조 서비스, 환경 및 규제 서비스, 의료 관리 시스템 인증 및 감사, 임상 연구 서비스, 컨설팅 서비스 및 기타 서비스), 기술별(PCR, 실시간 PCR, 차세대 시퀀싱 및 기타 기술), 최종 사용자(병원, 진단 센터, 학술 및 연구 기관 및 기타). |
|
적용 국가 |
독일, 프랑스, 영국, 이탈리아, 스페인, 네덜란드, 러시아, 덴마크, 스위스, 터키, 오스트리아, 노르웨이, 헝가리, 리투아니아, 아일랜드, 폴란드, 그리고 유럽의 나머지 국가. |
|
시장 참여자 포함 |
F. Hoffmann-La Roche Ltd, Danaher, BIOMERIEUX, QIAGEN, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc, Abbott, DiaSorin SpA, Hologic, Inc 등이 있습니다. |
시장 정의
분자 진단은 조직이나 체액에서 단백질, DNA, RNA와 같은 분자를 연구하여 질병을 식별하는 과정으로 알려져 있습니다. 이러한 분자 진단 서비스는 실험실의 기술을 사용하여 특정 분자를 연구, 분석 및 진단하는 전략으로 사용됩니다. 이는 특히 체액에서 특정 바이오마커 측정, 박테리아 유전자의 중합효소 연쇄 반응(PCR) 기반 감지 및 특정 감염의 분자 반응에 사용됩니다. 이러한 서비스는 보다 효율적인 검사 및 진단을 제공하는 데 사용됩니다.
분자 진단 서비스는 연구자와 기술자가 더 짧은 시간 안에 효율적이고 효과적으로 산출물을 생산할 수 있도록 하며, 이는 아시아 태평양 분자 진단 서비스 시장을 주도합니다. 또한 임상 실무의 잠재력을 통해 이러한 서비스는 분자 진단의 효율성을 높이기 위한 추가 지원을 제공하는 데 사용되며 주요 시장 참여자의 존재도 시장 성장에 기여합니다.
유럽 분자 진단 서비스 시장 역학
운전자
- 만성 및 감염성 질환의 유병률 증가
만성 및 감염성 질환은 현재 거의 모든 국가에서 성인 사망의 주요 원인입니다. 만성 및 감염성 질환의 유병률이 증가하고 있으며, 그 결과 사람들은 진단 실험실과 질병 진단 센터에 더 의존하게 되었습니다. 유병률이 증가함에 따라 더 짧은 시간 내에 정확한 진단, 치료 및 검사 결과를 제공하기 위한 분자 진단 서비스에 대한 수요가 증가했습니다. 건강에 해로운 행동, 특히 담배 사용, 신체 활동 부족, 나쁜 식습관 및 과도한 음주는 만성 및 감염성 질환의 유병률 증가에 크게 기여합니다. 이러한 질병은 면역 검정, 분자 기술, PCR 및 유전자 조작 기술 등 여러 기술을 통해 진단할 수 있습니다. 따라서 환자의 더 빠른 진단 및 치료에 대한 요구를 충족하기 위해 분자 진단 서비스에 대한 수요가 증가하고 있습니다.
만성 및 감염성 질환의 발생이 높고 진단 및 치료를 위한 분자 검사의 수도 증가했으며, 제품과 서비스에 대한 수요는 결국 증가할 것입니다. 따라서 만성 및 감염성 질환의 유병률이 증가함에 따라 전 세계적으로 시장 성장이 촉진되고 있습니다.
- 테스트, 치료 및 보다 빠른 진단에 대한 수요 증가
고가의 전문 치료에 대한 수요는 현재 시나리오에서 더 많습니다. 소비자들 사이에서 더 빠른 진단에 대한 인식이 높아지고 있으며 분자 진단을 위한 분석기 소프트웨어 채택이 더 빠른 속도로 증가하고 있습니다. 분자 진단은 정확하고 효과적인 결과를 제공하며 질병 진단에 없어서는 안 될 응용 분야가 있습니다. 사람들은 개인의 유전적, 후성유전체적, 임상적 정보를 식별하는 데 의존하는 개인화된 약물을 선호하고 있습니다.
게다가 최근 몇 년 동안 환자들은 개인화된 치료와 관리를 선호하고 있으며, 분자 검사, 치료법, 보다 빠른 진단에 대한 수요가 증가하고 있습니다. 이는 전 세계적으로 시장 성장을 촉진하는 요인이 될 수 있습니다.
- 분자 진단 부문의 자금 조달 증가
혁신과 개발을 지원하고 촉진하기 위한 정부 이니셔티브, 계획 및 자금 지원 활동이 증가하면서 분자 진단 분야가 빠르게 성장하고 있습니다. 이 분야는 질병 통제의 필수적인 부분이므로 자금 지원이 증가하고 과학자들은 질병 통제와 건강한 생존을 위한 새로운 아이디어를 개발하는 데 더 집중하고 있습니다. 다시 말하지만 암과 같은 만성 질환이 전 세계적으로 지배적이 되었고 전문 치료와 가장 빠른 진단에 대한 수요가 증가하고 있습니다.
정부와 공공 자금이 분자 진단 부문을 지원하기 위해 더 나은 혁신과 더 빠른 진단을 위한 대안을 늘리면서 시장이 더 크게 성장하고 있습니다. 위의 사례를 고려하면 분자 진단 부문의 자금이 증가하면서 가까운 미래에 시장이 주도될 것으로 예측할 수 있습니다.
기회
-
연구 개발 활동 확대
증가하는 R&D 활동은 전 세계적으로 분자 진단 서비스를 받을 수 있는 대안을 제공하며, 접근성을 개선하고 진단 서비스와 관련된 비용을 절감합니다. 그러나 분자 진단의 잠재력은 느리고 단편적인 도입으로 실현되지 않았습니다.
인식 프로그램의 증가, 인식 이니셔티브의 증가, 정부의 지원으로 다양한 분야에서 분자 진단 사용이 증가했습니다. R&D 활동의 증가는 새로운 제품이나 개선된 제품과 프로세스를 개발하는 데 필요한 지식을 늘리는 데 도움이 될 것입니다. 설계, 기술 제조, 단계적 시험은 종종 서비스 개선을 제공하는 R&D 활동의 가장 중요한 부분입니다.
시장 참여자들이 끊임없이 R&D 활동에 참여함에 따라 더 많은 분자 진단 서비스가 시장에 참여할 가능성이 높습니다. 이는 병원, 진료소, 진단 센터와 같은 다양한 최종 사용자의 분자 진단 서비스에 대한 수요를 증가시킬 것입니다.
제지/도전
- 분자 진단 연구실 설비 및 기타 계측기와 관련된 높은 비용
분자 진단 실험실은 형광 현장 교잡(FISH), 중합효소 연쇄 반응(PCR) 기반 분자 진단, 계면 염색체 프로파일링, DNA 지문 등과 같은 여러 기술을 포함합니다. 분자 진단 실험실과 관련된 여러 서비스가 있는데, 설치 서비스, 검증 서비스, 정류 서비스, 자동화 서비스 등이 있습니다. 따라서 전체 실험실 설치 및 계측 비용이 너무 높아 정부와 민간의 자금과 투자 없이는 설립하기가 매우 어렵고, 이는 시장 성장을 제한할 수 있습니다.
COVID-19 이후 유럽 분자 진단 서비스 시장에 미치는 영향
COVID-19 이후는 시장에 긍정적인 영향을 미쳤습니다. 많은 인구가 이 팬데믹의 영향을 받았고 전 세계적으로 진단 검사 수가 증가했습니다. 대부분 PCR 기반 COVID-19 진단이 증가했습니다. 따라서 COVID-19는 시장에 긍정적인 영향을 미쳤습니다.
최근 개발
- 2022년 10월, F. Hoffmann-La Roche Ltd는 자가 검사 및 전문가용 CE 마크를 획득한 차세대 SARS-CoV-2 신속 항원 검사("2.0") 포트폴리오를 출시했습니다. 이를 통해 회사는 조직에서 이러한 혁신을 통해 소비자에게 더 나은 서비스를 제공할 수 있었습니다.
유럽 분자 진단 서비스 시장 범위
유럽 분자 진단 서비스 시장은 서비스 유형, 기술 및 최종 사용자를 기준으로 세 가지 주요 세그먼트로 세분화됩니다. 이러한 세그먼트 간의 성장은 산업의 빈약한 성장 세그먼트를 분석하고 사용자에게 핵심 시장 응용 프로그램을 식별하기 위한 전략적 결정을 내릴 수 있는 귀중한 시장 개요와 시장 통찰력을 제공하는 데 도움이 됩니다.
서비스 유형별
- 악기 수리 서비스
- 교육 서비스
- 유지 보수 서비스
- 교정 서비스
- 컴플라이언스 서비스
- 턴키 서비스
- 확장 가능한 자동화 서비스
- 하드웨어 사용자 정의
- 악기 이전 서비스
- 성과 보증 서비스
- 디자인 및 개발 서비스
- 공급망 솔루션
- 신제품 소개 서비스
- 제조 서비스
- 환경 및 규제 서비스
- 의료 관리 시스템 인증 및 감사
- 임상 연구 서비스
- 컨설팅 서비스
- 기타 서비스
서비스 유형에 따라 시장은 계측기 수리 서비스, 교육 서비스, 유지 보수 서비스, 교정 서비스, 규정 준수 서비스, 턴키 서비스, 확장 가능한 자동화 서비스, 하드웨어 사용자 정의, 계측기 이전 서비스, 성능 보증 서비스, 설계 및 개발 서비스, 공급망 솔루션, 신제품 출시 서비스, 제조 서비스, 환경 및 규제 서비스, 의료 관리 시스템 인증 및 감사, 임상 연구 서비스, 컨설팅 서비스 및 기타 서비스로 세분화됩니다.
기술로
- PCR
- 실시간 PCR
- 차세대 시퀀싱
- 기타 기술
기술은 PCR, 실시간 PCR, 차세대 시퀀싱 및 기타 기술로 세분화됩니다.
최종 사용자별
- 병원
- 진단 센터
- 학술 및 연구 기관
- 기타
최종 사용자를 기준으로 시장은 병원, 진단 센터, 학술 및 연구 기관 및 기타로 세분화됩니다.
유럽 분자 진단 서비스 시장 지역 분석/통찰력
유럽 분자 진단 서비스 시장을 분석하고, 국가, 서비스 유형, 기술 및 최종 사용자별로 시장 규모에 대한 통찰력과 추세를 제공합니다.
이 보고서에서 다루는 국가는 독일, 프랑스, 영국, 이탈리아, 스페인, 네덜란드, 러시아, 덴마크, 스위스, 터키, 오스트리아, 노르웨이, 헝가리, 리투아니아, 아일랜드, 폴란드, 그리고 나머지 유럽 국가입니다.
독일은 시장 점유율과 시장 수익 면에서 유럽 분자 진단 서비스 시장을 지배하고 있으며, 예측 기간 동안에도 그 지배력을 계속 확대할 것입니다.
이는 사람들 사이에서 인식 프로그램을 시행하고 기술이 발전함에 따라 시장 성장이 더욱 개선되었기 때문입니다.
보고서의 국가 섹션은 또한 현재 및 미래 시장 추세에 영향을 미치는 개별 시장 영향 요인과 시장 규정의 변화를 제공합니다. 신규 및 교체 판매, 국가 인구 통계, 질병 역학 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 유럽 브랜드의 존재 및 가용성과 국내 및 국내 브랜드와의 치열한 경쟁으로 인해 직면한 과제, 판매 채널의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.
경쟁 환경 및 유럽 분자 진단 서비스 시장 점유율 분석
유럽 분자 진단 서비스 시장 경쟁 구도는 경쟁자에 대한 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, R&D 투자, 새로운 시장 이니셔티브, 유럽 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 프로그램 우세입니다. 제공된 위의 데이터 포인트는 회사의 시장 집중과만 관련이 있습니다.
유럽 분자 진단 서비스 시장에서 활동하는 주요 기업으로는 F. Hoffmann-La Roche Ltd, Danaher, BIOMERIEUX, QIAGEN, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc, Abbott, DiaSorin SpA, Hologic, Inc 등이 있습니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 SERVICE TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 RISING PREVALENCE OF CHRONIC AND INFECTIOUS DISEASES
5.1.2 INCREASING DEMAND FOR TESTING, THERAPIES, AND FASTER DIAGNOSTICS
5.1.3 GROWING FUNDINGS IN MOLECULAR DIAGNOSTICS SEGMENT
5.2 RESTRAINTS
5.2.1 HIGH-COST ASSOCIATED WITH MOLECULAR DIAGNOSTICS LABS SET-UPS AND OTHER INSTRUMENTATIONS
5.2.2 NON-AVAILABILITY OF RELEVANT AND APPROPRIATE KITS
5.3 OPPORTUNITIES
5.3.1 STRATEGIC INITIATIVES BY KEY PLAYERS
5.3.2 RISING GOVERNMENT AND PRIVATE COLLABORATIONS
5.3.3 INCREASING RESEARCH AND DEVELOPMENT ACTIVITIES
5.4 CHALLENGES
5.4.1 STRINGENT REGULATIONS
5.4.2 LACK OF SKILLED PROFESSIONALS
6 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE
6.1 OVERVIEW
6.2 INSTRUMENT REPAIR SERVICES
6.2.1 ON-SITE REPAIR SERVICES
6.2.1 OFF-SITE REPAIR SERVICES
6.3 MAINTENANCE SERVICES
6.4 TRAINING SERVICES
6.4.1 PCR BASED MOLECULAR DIAGNOSTICS
6.4.2 IMMUNOHISTOCHEMISTRY (IHC)
6.4.3 VIRAL LOAD TESTING
6.4.4 INTERPHASE CHROMOSOME PROFILING (ICP)
6.4.5 APPLICATION TRAINING SERVICES
6.5 CALIBRATION SERVICES
6.6 COMPLIANCE SERVICES
6.6.1 IQ/OQ & PM/OQ SERVICES
6.6.2 INSTALLATION SERVICES
6.6.3 VALIDATION SERVICES
6.6.4 OTHER SERVICES
6.7 TURNKEY SERVICES
6.8 SCALABLE AUTOMATION SERVICES
6.8.1 AUTOMATION FOR HIGH-CONTENT SCREENING (HCS)
6.8.2 AUTOMATION FOR HIGH-THROUGHPUT PLATE-BASED ASSAYS
6.8.3 AUTOMATION FOR HIGH-THROUGHPUT CLONE SCREENING
6.9 HARDWARE CUSTOMIZATION
6.1 INSTRUMENT RELOCATION SERVICES
6.10.1 PLATE RECERTIFICATION
6.10.2 FACTORY-APPROVED PARTS
6.10.3 INSTRUMENT PERFORMANCE EVALUATION
6.10.4 OTHER SERVICES
6.11 PERFORMANCE ASSURANCE SERVICES
6.12 DESIGN AND DEVELOPMENT SERVICES
6.13 SUPPLY CHAIN SOLUTIONS
6.14 NEW PRODUCT INTRODUCTION SERVICES
6.15 MANUFACTURING SERVICES
6.16 ENVIRONMENTAL AND REGULATORY SERVICES
6.17 MEDICAL MANAGEMENT SYSTEMS CERTIFICATION & AUDITING
6.18 CLINICAL RESEARCH SERVICES
6.19 CONSULTATIVE SERVICES
6.2 OTHER SERVICES
7 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY
7.1 OVERVIEW
7.2 REAL TIME PCR
7.2.1 INSTRUMENT REPAIR SERVICES
7.2.2 MAINTENANCE SERVICES
7.2.3 TRAINING SERVICES
7.2.4 CALIBRATION SERVICES
7.2.5 COMPLIANCE SERVICES
7.2.6 TURNKEY SERVICES
7.2.7 SCALABLE AUTOMATION SERVICES
7.2.8 HARDWARE CUSTOMIZATION
7.2.9 INSTRUMENT RELOCATION SERVICES
7.2.10 PERFORMANCE ASSURANCE SERVICES
7.2.11 DESIGN AND DEVELOPMENT SERVICES
7.2.12 SUPPLY CHAIN SOLUTIONS
7.2.13 NEW PRODUCT INTRODUCTION SERVICES
7.2.14 MANUFACTURING SERVICES
7.2.15 ENVIRONMENTAL & REGULATION SERVICES
7.2.16 MEDICAL MANAGEMENT SYSTEMS CERTIFICATION & AUDITING
7.2.17 CLINICAL RESEARCH SERVICES
7.2.18 CONSULTATIVE SERVICES
7.2.19 OTHER SERVICES
7.3 PCR
7.3.1 INSTRUMENT REPAIR SERVICES
7.3.2 MAINTENANCE SERVICES
7.3.3 TRAINING SERVICES
7.3.4 CALIBRATION SERVICES
7.3.5 COMPLIANCE SERVICES
7.3.6 TURNKEY SERVICES
7.3.7 SCALABLE AUTOMATION SERVICES
7.3.8 HARDWARE CUSTOMIZATION
7.3.9 INSTRUMENT RELOCATION SERVICES
7.3.10 PERFORMANCE ASSURANCE SERVICES
7.3.11 DESIGN AND DEVELOPMENT SERVICES
7.3.12 SUPPLY CHAIN SOLUTIONS
7.3.13 NEW PRODUCT INTRODUCTION SERVICES
7.3.14 MANUFACTURING SERVICES
7.3.15 ENVIRONMENTAL AND REGULATION SERVICES
7.3.16 MEDICAL MANAGEMENT SYSTEMS CERTIFICATION & AUDITING
7.3.17 CLINICAL RESEARCH SERVICES
7.3.18 CONSULTATIVE SERVICES
7.3.19 OTHER SERVICES
7.4 NEXT GENERATION SEQUENCING
7.4.1 INSTRUMENT REPAIR SERVICES
7.4.2 MAINTENANCE SERVICES
7.4.3 TRAINING SERVICES
7.4.4 CALIBRATION SERVICES
7.4.5 COMPLIANCE SERVICES
7.4.6 TURNKEY SERVICES
7.4.7 SCALABLE AUTOMATION SERVICES
7.4.8 HARDWARE CUSTOMIZATION
7.4.9 INSTRUMENT RELOCATION SERVICES
7.4.10 PERFORMANCE ASSURANCE SERVICES
7.4.11 DESIGN AND DEVELOPMENT SERVICES
7.4.12 SUPPLY CHAIN SOLUTIONS
7.4.13 NEW PRODUCT INTRODUCTION SERVICES
7.4.14 MANUFACTURING SERVICES
7.4.15 ENVIRONMENTAL AND REGULATION SERVICES
7.4.16 MEDICAL MANAGEMENT SYSTEMS CERTIFICATION & AUDITING
7.4.17 CLINICAL RESEARCH SERVICES
7.4.18 CONSULTATIVE SERVICES
7.4.19 OTHER SERVICES
7.5 OTHER TECHNOLOGIES
8 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER
8.1 OVERVIEW
8.2 HOSPITALS
8.2.1 INSTRUMENT REPAIR SERVICES
8.2.2 MAINTENANCE SERVICES
8.2.3 TRAINING SERVICES
8.2.4 CALIBRATION SERVICES
8.2.5 COMPLIANCE SERVICES
8.2.6 TURNKEY SERVICES
8.2.7 SCALABLE AUTOMATION SERVICES
8.2.8 HARDWARE CUSTOMIZATION
8.2.9 INSTRUMENT RELOCATION SERVICES
8.2.10 PERFORMANCE ASSURANCE SERVICES
8.2.11 DESIGN AND DEVELOPMENT SERVICES
8.2.12 SUPPLY CHAIN SOLUTIONS
8.2.13 NEW PRODUCT INTRODUCTION SERVICES
8.2.14 MANUFACTURING SERVICES
8.2.15 ENVIRONMENTAL AND REGULATORY SERVICES
8.2.16 MEDICAL MANAGEMENT SYSTEMS CERTIFICATION AND AUDITING
8.2.17 CLINICAL RESEARCH SERVICES
8.2.18 CONSULTATIVE SERVICES
8.2.19 OTHER SERVICES
8.3 DIAGNOSTIC CENTERS
8.3.1 CLINICAL LABORATORIES
8.3.1.1 INSTRUMENT REPAIR SERVICES
8.3.1.2 Maintenance services
8.3.1.3 Training SERVICES
8.3.1.4 CALIBRATION SERVICES
8.3.1.5 COMPLIANCE SERVICES
8.3.1.6 TURNKEY SERVICES
8.3.1.7 SCALABLE AUTOMATION SERVICES
8.3.1.8 HARDWARE CUSTOMIZATION
8.3.1.9 INSTRUMENT RELOCATION SERVICES
8.3.1.10 PERFORMANCE Assurance SERVICES
8.3.1.11 DESIGN and DEVELOPMENT SERVICES
8.3.1.12 SUPPLY CHAIN SOLUTIONS
8.3.1.13 NEW PRODUCT INTRODUCTION SERVICES
8.3.1.14 MANUFACTURING SERVICES
8.3.1.15 ENVIRONMENTAL and REGULATory SERVICES
8.3.1.16 MEDICAL MANAGEMENT SYSTEMS CERTIFICATION and AUDITING
8.3.1.17 CLINICAL RESEARCH SERVICES
8.3.1.18 CONSULTATIVE SERVICES
8.3.1.19 Other SERVICES
8.3.2 AMBULATORY SURGICAL CENTERS
8.3.2.1 INSTRUMENT REPAIR SERVICES
8.3.2.2 MAINTENANCE SERVICES
8.3.2.3 TRAINING SERVICES
8.3.2.4 CALIBRATION SERVICES
8.3.2.5 COMPLIANCE SERVICES
8.3.2.6 TURNKEY SERVICES
8.3.2.7 SCALABLE AUTOMATION SERVICES
8.3.2.8 HARDWARE CUSTOMIZATION
8.3.2.9 INSTRUMENT RELOCATION SERVICES
8.3.2.10 PERFORMANCE Assurance SERVICES
8.3.2.11 DESIGN and DEVELOPMENT SERVICES
8.3.2.12 SUPPLY CHAIN SOLUTIONS
8.3.2.13 NEW PRODUCT INTRODUCTION SERVICES
8.3.2.14 MANUFACTURING SERVICES
8.3.2.15 ENVIRONMENTAL AND REGULATORY SERVICES
8.3.2.16 MEDICAL MANAGEMENT SYSTEMS CERTIFICATION and AUDITING
8.3.2.17 CLINICAL RESEARCH SERVICES
8.3.2.18 CONSULTATIVE SERVICES
8.3.2.19 OTHER SERVICES
8.4 ACADEMIC AND RESEARCH INSTITUTES
8.4.1 INSTRUMENT REPAIR SERVICES
8.4.2 MAINTENANCE SERVICES
8.4.3 TRAINING SERVICES
8.4.4 CALIBRATION SERVICES
8.4.5 COMPLIANCE SERVICES
8.4.6 TURNKEY SERVICES
8.4.7 SCALABLE AUTOMATION SERVICES
8.4.8 HARDWARE CUSTOMIZATION
8.4.9 INSTRUMENT RELOCATION SERVICES
8.4.10 PERFORMANCE ASSURANCE SERVICES
8.4.11 DESIGN AND DEVELOPMENT SERVICES
8.4.12 SUPPLY CHAIN SOLUTIONS
8.4.13 NEW PRODUCT INTRODUCTION SERVICES
8.4.14 MANUFACTURING SERVICES
8.4.15 ENVIRONMENTAL AND REGULATORY SERVICES
8.4.16 MEDICAL MANAGEMENT SYSTEMS CERTIFICATION & AUDITING
8.4.17 CLINICAL RESEARCH SERVICES
8.4.18 CONSULTATIVE SERVICES
8.4.19 OTHER SERVICES
8.5 OTHERS
9 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION
9.1 EUROPE
9.1.1 GERMANY
9.1.2 FRANCE
9.1.3 U.K.
9.1.4 ITALY
9.1.5 SPAIN
9.1.6 RUSSIA
9.1.7 NETHERLANDS
9.1.8 SWITZERLAND
9.1.9 SWEDEN
9.1.10 BELGIUM
9.1.11 NORWAY
9.1.12 POLAND
9.1.13 DENMARK
9.1.14 TURKEY
9.1.15 FINLAND
9.1.16 REST OF EUROPE
10 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS: EUROPE
11 SWOT ANALYSIS
12 COMPANY PROFILE
12.1 F.HOFFMANN-LA ROCHE LTD
12.1.1 COMPANY SNAPSHOT
12.1.2 REVENUE ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 SERVICE PORTFOLIO
12.1.5 RECENT DEVELOPMENT
12.2 DANAHER
12.2.1 COMPANY SNAPSHOT
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENT
12.3 BIOMERIEUX
12.3.1 COMPANY SNAPSHOT
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHARE ANALYSIS
12.3.4 SERVICE PORTFOLIO
12.3.5 RECENT DEVELOPMENT
12.4 QIAGEN
12.4.1 COMPANY SNAPSHOT
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHARE ANALYSIS
12.4.4 SERVICE PORTFOLIO
12.4.5 RECENT DEVELOPMENT
12.5 THERMO FISHER SCIENTIFIC
12.5.1 COMPANY SNAPSHOT
12.5.2 REVENUE ANALYSIS
12.5.3 COMPANY SHARE ANALYSIS
12.5.4 SERVICE PORTFOLIO
12.5.5 RECENT DEVELOPMENT
12.6 ABBOTT
12.6.1 COMPANY SNAPSHOT
12.6.2 REVENUE ANALYSIS
12.6.3 SERVICE PORTFOLIO
12.6.4 RECENT DEVELOPMENT
12.7 BIO-RAD LABORATORIES, INC
12.7.1 COMPANY SNAPSHOT
12.7.2 REVENUE ANALYSIS
12.7.3 SERVICE PORTFOLIO
12.7.4 RECENT DEVELOPMENTS
12.8 DIASORIN
12.8.1 COMPANY SNAPSHOT
12.8.2 REVENUE ANALYSIS
12.8.3 SERVICE PORTFOLIO
12.8.4 RECENT DEVELOPMENT
12.9 HOLOGIC, INC
12.9.1 COMPANY SNAPSHOT
12.9.2 REVENUE ANALYSIS
12.9.3 SERVICE PORTFOLIO
12.9.4 RECENT DEVELOPMENT
13 QUESTIONNAIRE
14 RELATED REPORTS
표 목록
TABLE 1 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 1 EUROPE INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 2 EUROPE INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 3 EUROPE MAINTENANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 4 EUROPE TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 5 EUROPE TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 6 EUROPE CALIBRATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 7 EUROPE COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 8 EUROPE COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 9 EUROPE TURNKEY SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 10 EUROPE SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 11 EUROPE SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 12 EUROPE HARDWARE CUSTOMIZATION IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 13 EUROPE INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 14 EUROPE INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 15 EUROPE PERFORMANCE ASSURANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 16 EUROPE DESIGN AND DEVELOPMENT SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 17 EUROPE SUPPLY CHAIN SOLUTIONS SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 18 EUROPE NEW PRODUCT INTRODUCTION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 19 EUROPE MANUFACTURING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 20 EUROPE ENVIRONMENTAL AND REGULATORY SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 21 EUROPE MEDICAL MANAGEMENT SYSTEMS AND AUDITING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 22 EUROPE CLINICAL RESEARCH SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 23 EUROPE CONSULTATIVE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 24 EUROPE OTHER SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 25 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 26 EUROPE REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 27 EUROPE REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 28 EUROPE PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 29 EUROPE PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 30 EUROPE NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 31 EUROPE NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 32 EUROPE OTHER TECHNOLOGIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 33 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 34 EUROPE HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 35 EUROPE HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 36 EUROPE DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 37 EUROPE DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 38 EUROPE CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 39 EUROPE AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 40 EUROPE ACADEMIC AND RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 41 EUROPE ACADEMIC AND RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 42 EUROPE OTHERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 43 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)
TABLE 44 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 45 EUROPE INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 46 EUROPE TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 47 EUROPE COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 48 EUROPE SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 49 EUROPE INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 50 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 51 EUROPE REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 52 EUROPE PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 53 EUROPE NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 54 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 55 EUROPE HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE 2021-2030 (USD THOUSAND)
TABLE 56 EUROPE DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 57 EUROPE CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 58 EUROPE AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 59 EUROPE ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 60 GERMANY MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 61 GERMANY INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 62 GERMANY TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 63 GERMANY COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 64 GERMANY SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 65 GERMANY INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 66 GERMANY MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 67 GERMANY REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 68 GERMANY PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 69 GERMANY NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 70 GERMANY MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 71 GERMANY HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 72 GERMANY DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 73 GERMANY CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 74 GERMANY AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 75 GERMANY ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 76 FRANCE MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 77 FRANCE INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 78 FRANCE TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 79 FRANCE COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 80 FRANCE SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 81 FRANCE INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 82 FRANCE MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 83 FRANCE REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 84 FRANCE PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 85 FRANCE NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 86 FRANCE MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 87 FRANCE HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 88 FRANCE DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 89 FRANCE CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 90 FRANCE AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 91 FRANCE ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 92 U.K. MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 93 U.K. INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 94 U.K. TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 95 U.K. COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 96 U.K. SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 97 U.K. INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 98 U.K. MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 99 U.K. REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 100 U.K. PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 101 U.K. NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 102 U.K. MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 103 U.K. HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 104 U.K. DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 105 U.K. CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 106 U.K. AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 107 U.K. ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 108 ITALY MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 109 ITALY INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 110 ITALY TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 111 ITALY COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 112 ITALY SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 113 ITALY INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 114 ITALY MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 115 ITALY REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 116 ITALY PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 117 ITALY NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 118 ITALY MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 119 ITALY HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 120 ITALY DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 121 ITALY CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 122 ITALY AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 123 ITALY ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 124 SPAIN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 125 SPAIN INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 126 SPAIN TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 127 SPAIN COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 128 SPAIN SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 129 SPAIN INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 130 SPAIN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 131 SPAIN REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 132 SPAIN PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 133 SPAIN NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 134 SPAIN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 135 SPAIN HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 136 SPAIN DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 137 SPAIN CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 138 SPAIN AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 139 SPAIN ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 140 RUSSIA MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 141 RUSSIA INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 142 RUSSIA TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 143 RUSSIA COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 144 RUSSIA SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 145 RUSSIA INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 146 RUSSIA MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 147 RUSSIA REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 148 RUSSIA PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 149 RUSSIA NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 150 RUSSIA MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 151 RUSSIA HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 152 RUSSIA DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 153 RUSSIA CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 154 RUSSIA AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 155 RUSSIA ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 156 NETHERLANDS MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 157 NETHERLANDS INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 158 NETHERLANDS TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 159 NETHERLANDS COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 160 NETHERLANDS SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 161 NETHERLANDS INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 162 NETHERLANDS MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 163 NETHERLANDS REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 164 NETHERLANDS PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 165 NETHERLANDS NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 166 NETHERLANDS MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 167 NETHERLANDS HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 168 NETHERLANDS DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 169 NETHERLANDS CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 170 NETHERLANDS AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 171 NETHERLANDS ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 172 SWITZERLAND MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 173 SWITZERLAND INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 174 SWITZERLAND TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 175 SWITZERLAND COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 176 SWITZERLAND SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 177 SWITZERLAND INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 178 SWITZERLAND MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 179 SWITZERLAND REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 180 SWITZERLAND PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 181 SWITZERLAND NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 182 SWITZERLAND MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 183 SWITZERLAND HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 184 SWITZERLAND DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 185 SWITZERLAND CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 186 SWITZERLAND AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 187 SWITZERLAND ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 188 SWEDEN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 189 SWEDEN INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 190 SWEDEN TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 191 SWEDEN COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 192 SWEDEN SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 193 SWEDEN INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 194 SWEDEN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 195 SWEDEN REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 196 SWEDEN PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 197 SWEDEN NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 198 SWEDEN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 199 SWEDEN HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 200 SWEDEN DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 201 SWEDEN CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 202 SWEDEN AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 203 SWEDEN ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 204 BELGIUM MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 205 BELGIUM INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 206 BELGIUM TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 207 BELGIUM COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 208 BELGIUM SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 209 BELGIUM INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 210 BELGIUM MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 211 BELGIUM REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 212 BELGIUM PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 213 BELGIUM NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 214 BELGIUM MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 215 BELGIUM HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 216 BELGIUM DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 217 BELGIUM CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 218 BELGIUM AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 219 BELGIUM ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 220 NORWAY MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 221 NORWAY INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 222 NORWAY TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 223 NORWAY COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 224 NORWAY SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 225 NORWAY INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 226 NORWAY MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 227 NORWAY REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 228 NORWAY PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 229 NORWAY NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 230 NORWAY MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 231 NORWAY HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 232 NORWAY DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 233 NORWAY CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 234 NORWAY AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 235 NORWAY ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 236 POLAND MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 237 POLAND INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 238 POLAND TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 239 POLAND COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 240 POLAND SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 241 POLAND INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 242 POLAND MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 243 POLAND REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 244 POLAND PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 245 POLAND NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 246 POLAND MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 247 POLAND HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 248 POLAND DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 249 POLAND CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 250 POLAND AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 251 POLAND ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 252 DENMARK MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 253 DENMARK INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 254 DENMARK TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 255 DENMARK COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 256 DENMARK SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 257 DENMARK INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 258 DENMARK MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 259 DENMARK REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 260 DENMARK PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 261 DENMARK NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 262 DENMARK MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 263 DENMARK HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 264 DENMARK DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 265 DENMARK CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 266 DENMARK AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 267 DENMARK ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 268 TURKEY MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 269 TURKEY INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 270 TURKEY TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 271 TURKEY COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 272 TURKEY SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 273 TURKEY INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 274 TURKEY MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 275 TURKEY REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 276 TURKEY PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 277 TURKEY NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 278 TURKEY MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 279 TURKEY HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 280 TURKEY DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 281 TURKEY CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 282 TURKEY AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 283 TURKEY ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 284 FINLAND MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 285 FINLAND INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 286 FINLAND TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 287 FINLAND COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 288 FINLAND SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 289 FINLAND INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 290 FINLAND MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 291 FINLAND REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 292 FINLAND PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 293 FINLAND NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 294 FINLAND MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 295 FINLAND HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 296 FINLAND DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 297 FINLAND CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 298 FINLAND AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 299 FINLAND ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 300 REST OF EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
그림 목록
FIGURE 1 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: SEGMENTATION
FIGURE 2 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: DROC ANALYSIS
FIGURE 4 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: SEGMENTATION
FIGURE 11 THE RISING PREVALENCE OF CHRONIC AND INFECTIOUS DISEASES IS EXPECTED TO DRIVE THE EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 12 SERVICE TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET IN 2023 AND 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET
FIGURE 14 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET : BY SERVICE TYPE, 2022
FIGURE 15 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET : BY SERVICE TYPE, 2023-2030 (USD THOUSAND)
FIGURE 16 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET : BY SERVICE TYPE, CAGR (2023-2030)
FIGURE 17 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET : BY SERVICE TYPE, LIFELINE CURVE
FIGURE 18 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: BY TECHNOLOGY, 2022
FIGURE 19 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: BY TECHNOLOGY, 2023-2030 (USD THOUSAND)
FIGURE 20 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: BY TECHNOLOGY, CAGR (2023-2030)
FIGURE 21 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET : BY TECHNOLOGY, LIFELINE CURVE
FIGURE 22 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: BY END USER, 2022
FIGURE 23 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: BY END USER, 2023-2030 (USD THOUSAND)
FIGURE 24 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: BY END USER, CAGR (2023-2030)
FIGURE 25 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET : BY END USER, LIFELINE CURVE
FIGURE 26 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: SNAPSHOT (2022)
FIGURE 27 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: BY COUNTRY (2022)
FIGURE 28 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: BY COUNTRY (2023 & 2030)
FIGURE 29 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: BY COUNTRY (2022 & 2030)
FIGURE 30 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: BY SERVICE TYPE (2023-2030)
FIGURE 31 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: COMPANY SHARE 2022 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
